Mark Krul

Mark Krul is the Director of Aglaia Oncology Funds, with a background in immunology and oncology. He has founded Aglaia Oncology Fund II and has held key roles in companies like Inthera Bioscience and Cristal Therapeutics, investing in pharmaceuticals and biotech sectors. Krul's career highlights include founding Aglaia Oncology Fund II and serving as Chief Scientific Officer at Oncode Accelerator, showcasing his expertise in oncology and drug development. His investments in companies like Inthera Bioscience and Cristal Therapeutics demonstrate his commitment to advancing innovative technologies in the pharmaceutical and biotech sectors.